Emergency and Trauma Centre, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Emerg Med Australas. 2022 Aug;34(4):547-554. doi: 10.1111/1742-6723.13929. Epub 2022 Jan 1.
To determine the burden, on the ED, of harm from unintentional adverse drug events (ADEs) in the community.
A retrospective, observational study of 936 randomly selected presentations to a level 6 ED at a principal referral hospital in Brisbane, Australia, in November 2017. Clinical records were screened by a pharmacist, who identified suspected ADEs. All suspected ADEs and a random selection of presentations without ADEs were reviewed by an expert panel, which classified, by consensus: occurrence and type of ADE, contribution of ADE to presentation, severity of harm and preventability of presentation. Medication-related ED presentations (ADE-Ps) and potential ADEs were, respectively, defined as presentations directly attributable to an ADE, and medication events that occurred but did not cause the ED presentation. Descriptive data analysis was performed.
The median (interquartile range) age of patients was 40 (27-58) years, with 49.7% (95% confidence interval [CI] 46.5-52.9) being male. The prevalences of ADE-Ps and potential ADEs were 9.2% (95% CI 7.5-11.3) and 5.0% (95% CI 3.8-6.6), respectively. The severity of harm was classified as 'death or likely permanent harm' in 4.7% (95% CI 0.2-9.1) of ADE-Ps, 'temporary harm' (89.5%, 95% CI 83.1-96.0) and 'minimal or no harm' (5.8%, 95% CI 0.9-10.8). Most (79.1%, 95% CI 70.5-87.7) ADE-Ps were preventable.
There is a high burden on emergency care because of unintended medication harm in the community. Interventions to reduce such harm are likely to require a co-ordinated primary, acute and public healthcare response. The high proportion of presentations with potential ADEs indicates opportunity for harm mitigation in the ED.
确定社区中无意药物不良事件(ADE)对急诊科(ED)的负担。
这是一项在澳大利亚布里斯班一家主要转诊医院的 6 级 ED 进行的回顾性、观察性研究,2017 年 11 月随机选择了 936 例就诊患者。药剂师筛查了临床记录,以发现疑似 ADE。所有疑似 ADE 和随机选择的无 ADE 就诊病例均由专家小组进行审查,专家小组通过共识对以下内容进行分类:ADE 的发生和类型、ADE 对就诊的贡献、伤害的严重程度和就诊的可预防程度。将与药物相关的 ED 就诊(ADE-P)和潜在 ADE 分别定义为直接归因于 ADE 的就诊,以及发生但未导致 ED 就诊的药物事件。进行了描述性数据分析。
患者的中位(四分位距)年龄为 40(27-58)岁,49.7%(95%置信区间 [CI] 46.5-52.9)为男性。ADE-P 和潜在 ADE 的患病率分别为 9.2%(95%CI 7.5-11.3)和 5.0%(95%CI 3.8-6.6)。伤害的严重程度被归类为 ADE-P 中 4.7%(95%CI 0.2-9.1)为“死亡或可能永久性伤害”,89.5%(95%CI 83.1-96.0)为“暂时伤害”和 5.8%(95%CI 0.9-10.8)为“最小或无伤害”。大多数(79.1%,95%CI 70.5-87.7)ADE-P 是可以预防的。
社区中无意药物伤害给急诊护理带来了沉重负担。减少此类伤害的干预措施可能需要初级、急性和公共医疗保健的协调响应。具有潜在 ADE 的就诊病例比例较高表明 ED 有减轻伤害的机会。